AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed Mar. 23, 2020 AGC Inc. (TYO:5201) recently announced that it intends to launch a tender offer for the acquisition of MolMed S.p.A., an…... Please subscribe to read the full story. Subscribe Free Trial